Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epirich Cera Daily Moisturizing Lotion is a topical dermatological formulation developed by Silamed, designed to restore and maintain the skin's natural protective barrier. The product is characterized by the inclusion of ceramides (indicated by the "Cera" designation), which are essential lipids that help repair the stratum corneum and prevent transepidermal water loss (TEWL). It typically incorporates humectants such as hyaluronic acid and glycerin to attract and retain moisture in the skin. The lotion is indicated for the management of dry, sensitive skin conditions, including xerosis and atopic dermatitis, providing long-lasting hydration and protection against environmental irritants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Epirich Cera Daily Moisturizing Lotion.